| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |